88IV - PR Newswire Asia's news


CStone 2026 Interim Results: Accelerating Pipeline 2.0 Execution and Sustained Global Commercial Momentum CS2009 Achieved Key Clinical Validations for Efficacy and Safety ... 2026-08-31T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
T-MAXIMUM B7-H3-Targeted Allogeneic CAR-T Therapy MT027 Receives FDA Fast Track Designation, Accelerating Global Development for Intracranial Solid Tumors MT027 has previously been granted FDA Orphan Drug Designation and has entered Phase II clinical development in recurrent glioblastoma ... 2026-08-31T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Samsung Biologics publishes prospectus for PolyPeptide public tender offer Direct subsidiary Samsung Peptide AG acting as formal offeror of the public tender offer Publication of offer prospectus follows pre-announcement on July 20, 2026 Largest individual shareholder committed ... 2026-08-31T Biotechnology Chemical Health Care/Hospital Medical/Pharmaceuticals
SIBIONICS Showcases GS3 in Melbourne, Advancing More Efficient, AI-Powered Glucose Monitoring MELBOURNE, Australia , Aug. 31, 2026 /PRNewswire/ -- SIBIONICS showcased its sensor innovation and AI-powered glucose monitoring at the joint IDF-WPR, ADC and Metabolic Diseases 2026 congress, held in ... 2026-08-31T Biotechnology Computer/Electronics Electronic Components
Chula Researchers Develop Synthetic Boar Scent Mimicking Natural Pheromones to Reduce Disease Outbreak Risks in Pig Farms BANGKOK , Aug. 31, 2026 /PRNewswire/ -- Researchers from Chulalongkorn University 's Faculty of Veterinary Science have developed synthetic boar scent mimicking natural pheromones , providing ... 2026-08-31T Agriculture Biotechnology Chemical Higher Education
Amai Proteins' sweelin® Approved for Sale in Israel, Opening the Market to a New Generation of Reduced-Sugar Food and Beverage Products Third regulatory approval in less than six months enables food and beverage manufacturers to commercialize products sweetened with sweelin® in Israel. ... 2026-08-31T Beverages Biotechnology Food/Beverages Health Care/Hospital
Subsidised Access to Columvi® Now Available for Eligible Patients with Relapsed or Refractory DLBCL in Singapore Columvi (glofitamab) will be added to the Cancer Drug List (CDL) and Medication Assistance Fund (MAF) on 1 September 2026 for eligible patients with relapsed or refractory diffuse large B-cell lymphoma ... 2026-08-31T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
WuXi AppTec Continues to Reward Shareholders, Further Increasing Interim Dividend to RMB 1.51 Billion SHANGHAI , Aug. 31, 2026 /PRNewswire/ -- WuXi AppTec Co., Ltd. (Stock Codes: 603259.SH/2359.HK), a leading global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organization), ... 2026-08-31T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Ascletis Announces First Participant Dosed in a Global Phase III Clinical Program of Once-Daily Oral Small Molecule GLP-1 Receptor Agonist ASC30 for Chronic Weight Management - Expected to enroll approximately 4,600 participants with obesity or overweight across two pivotal trials (AURORA-1 and AURORA-2) in the U.S., Europe, and Canada. ... 2026-08-30T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
LifeTech Scientific Corporation Announces 2026 Interim Results HONG KONG , Aug. 29, 2026 /PRNewswire/ -- LifeTech Scientific Corporation ("LifeTech" or the "Company", together with its subsidiaries, the "Group", stock code: 1302.HK), ... 2026-08-29T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals

PR Newswire Asia's news > Biotechnology